诺瓦瓦克斯医药(NVAX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NVAX 诺瓦瓦克斯医药

已收盘 07-02 16:00:00 EDT

12.97

+0.24

+1.89%

盘后12.89

-0.08-0.62%

19:59 EDT

最高13.12	最低12.55	成交量377.05万
今开12.79	昨收12.73	日振幅4.48%
总市值18.21亿	流通市值15.89亿	总股本1.40亿
成交额4,841万	换手率3.08%	流通股本1.22亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NVAX","market":"US","secType":"STK","nameCN":"诺瓦瓦克斯医药","latestPrice":12.97,"timestamp":1719950400000,"preClose":12.73,"halted":0,"volume":3770452,"hourTrading":{"tag":"盘后","latestPrice":12.89,"preClose":12.97,"latestTime":"19:59 EDT","volume":85504,"amount":1107986.9262,"timestamp":1719964771294},"delay":0,"floatShares":122475001,"shares":140417976,"eps":-3.491075,"marketStatus":"已收盘","marketStatusCode":5,"change":0.24,"latestTime":"07-02 16:00:00 EDT","open":12.79,"high":13.12,"low":12.55,"amount":48406205.222956,"amplitude":0.044776,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.491075,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1719993600000},"adr":0,"adjPreClose":12.73,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":12.8,"preClose":12.73,"latestTime":"09:29 EDT","volume":40989,"amount":518058.04451700003,"timestamp":1719926954054},"postHourTrading":{"tag":"盘后","latestPrice":12.89,"preClose":12.97,"latestTime":"19:59 EDT","volume":85504,"amount":1107986.9262,"timestamp":1719964771294},"volumeRatio":0.494187,"impliedVol":0.9584,"impliedVolPercentile":0.1071},"requestUrl":"/m/hq/s/NVAX","defaultTab":"news","newsList":[{"id":"2448915352","title":"诺瓦瓦克斯医药盘中异动 早盘急速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448915352","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448915352?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:40","pubTimestamp":1719841206,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日21时40分，诺瓦瓦克斯医药股票出现波动，股价大幅上涨5.06%。截至发稿，该股报13.30美元/股，成交量72.0555万股，换手率0.49%，振幅4.86%。诺瓦瓦克斯医药股票所在的生物技术行业中，整体涨幅为0.57%。诺瓦瓦克斯医药公司简介：诺瓦瓦克斯医药公司是一家开发疫苗的生物技术公司。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗，以应对已知和新出现的疾病威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701214006941f2be3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701214006941f2be3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4547","BK4568","NVAX","BK4585"],"gpt_icon":0},{"id":"2446595386","title":"更新版 1-美国疾病预防控制中心顾问建议六个月及以上人群接种最新的 COVID 疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2446595386","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446595386?lang=zh_cn&edition=full","pubTime":"2024-06-28 05:16","pubTimestamp":1719523011,"startTime":"0","endTime":"0","summary":"     路透6月27日 - 美国疾病控制和预防中心的一个外部专家小组一致投票决定，建议在 2024-25 年的免疫接种活动中，根据美国食品和药物管理局的授权，在6 个月及以上的人群中 使用更新的 COVID-19 疫苗。美国食品和药物管理局的独立顾问、欧洲卫生监管机构和世界卫生组织曾寻求通过更新疫苗来针对 JN.1 株系。Novavax 本月初申请了 JN.1 靶向疫苗的授权，并表示可在 7 月中旬上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","NVAX","BK4548","BK4568","BK4139","BK4547","BK4585","MRNA","BK4588","BK4533","BK4501","BK4534","BK4551"],"gpt_icon":0},{"id":"2446593326","title":"美国疾病预防控制中心顾问建议 6 个月及以上儿童接种更新的 COVID 疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2446593326","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446593326?lang=zh_cn&edition=full","pubTime":"2024-06-28 04:54","pubTimestamp":1719521698,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透6月27日 - 美国疾病控制和预防中心的一个外部专家小组建议在 2024-25 年的免疫接种活动中，在六个月及以上的人群中使用经美国食品药品管理局批准的更新版 COVID-19 疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4535","BK4551","BK4548","BK4534","BK4532","BK4139","MRNA","BK4547","BK4501","BNTX","BK4568","BK4533","NVAX","BK4588"],"gpt_icon":0},{"id":"2446396514","title":"诺瓦瓦克斯医药盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446396514","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446396514?lang=zh_cn&edition=full","pubTime":"2024-06-26 21:41","pubTimestamp":1719409289,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日21时41分，诺瓦瓦克斯医药股票出现异动，股价大幅下挫5.00%。截至发稿，该股报13.30美元/股，成交量79.3825万股，换手率0.54%，振幅3.74%。机构评级方面，在所有6家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。诺瓦瓦克斯医药股票所在的生物技术行业中，整体跌幅为0.52%。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗，以应对已知和新出现的疾病威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626214129af8f57bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626214129af8f57bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVAX","BK4139","BK4585","BK4568","BK4588","BK4547"],"gpt_icon":0},{"id":"2444159617","title":"美银维持诺瓦瓦克斯医药中性评级，上调目标价至18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444159617","media":"格隆汇资讯","labels":["rating"],"top":-1,"share":"https://www.laohu8.com/m/news/2444159617?lang=zh_cn&edition=full","pubTime":"2024-06-17 17:01","pubTimestamp":1718614876,"startTime":"0","endTime":"0","summary":"美银证券：将诺瓦瓦克斯医药的目标价从12美元上调至18美元，维持“中性”评级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061717012695b922b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061717012695b922b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"rating","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVAX"],"gpt_icon":0},{"id":"2443673956","title":"诺瓦瓦克斯医药盘中异动，股价跌幅近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443673956","media":"自选股智能写手","labels":["movement"],"top":-1,"share":"https://www.laohu8.com/m/news/2443673956?lang=zh_cn&edition=full","pubTime":"2024-06-14 21:32","pubTimestamp":1718371952,"startTime":"0","endTime":"0","summary":"诺瓦瓦克斯医药公司是一家开发疫苗的生物技术公司。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614213232968144de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614213232968144de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVAX"],"gpt_icon":1},{"id":"2443559577","title":"诺瓦瓦克斯医药盘中异动 下午盘股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443559577","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443559577?lang=zh_cn&edition=full","pubTime":"2024-06-13 02:46","pubTimestamp":1718217969,"startTime":"0","endTime":"0","summary":"北京时间2024年06月13日02时46分，诺瓦瓦克斯医药股票出现异动，股价大幅下跌5.05%。截至发稿，该股报15.88美元/股，成交量785.982万股，换手率5.34%，振幅7.12%。机构评级方面，在所有6家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。诺瓦瓦克斯医药股票所在的生物技术行业中，整体涨幅为0.95%。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗，以应对已知和新出现的疾病威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613024609aef49d72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613024609aef49d72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BK4139","BK4585","NVAX","BK4568","BK4588"],"gpt_icon":0},{"id":"2442823041","title":"美股异动 | 疫苗股走低 诺瓦瓦克斯医药(NVAX.US)跌超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442823041","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442823041?lang=zh_cn&edition=full","pubTime":"2024-06-10 23:29","pubTimestamp":1718033350,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周一，疫苗股走低，截至发稿，诺瓦瓦克斯医药(NVAX.US)跌超10%，Moderna(MRNA.US)跌2.8%，BioNTech(BNTX.US)跌超2%，辉瑞(PFE.US)跌超1.8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1133234.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4547","159646","BK4588","BK4139","BK4568","BK4585","NVAX"],"gpt_icon":0},{"id":"2442845231","title":"莫德纳新冠与流感综合疫苗试验有效，可能领先辉瑞及诺瓦瓦克斯医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2442845231","media":"鉅亨网","labels":["movement"],"top":-1,"share":"https://www.laohu8.com/m/news/2442845231?lang=zh_cn&edition=full","pubTime":"2024-06-10 18:56","pubTimestamp":1718016982,"startTime":"0","endTime":"0","summary":"其针对新冠病毒和流感的组合疫苗比针对这两种病毒的现有单独疫苗更有效。","market":"us","thumbnail":"https://cimg.cnyes.cool/prod/news/5593882/xs/0c0d9fcd6fa52bb291485a9021d3c97f.jpg","type":0,"news_type":0,"thumbnails":["https://cimg.cnyes.cool/prod/news/5593882/xs/0c0d9fcd6fa52bb291485a9021d3c97f.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://news.cnyes.com/news/id/5593882?exp=a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"cnyes_highlight","symbols":["NVAX","BNTX","MRNA","PFE"],"gpt_icon":0},{"id":"2441067204","title":"更新版 1-美国 FDA 称，COVID 注射应针对 2024-25 年的 JN.1 变异株","url":"https://stock-news.laohu8.com/highlight/detail?id=2441067204","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441067204?lang=zh_cn&edition=full","pubTime":"2024-06-07 23:10","pubTimestamp":1717773039,"startTime":"0","endTime":"0","summary":"     路透6月7日 - 美国食品和药物管理局周五建议 COVID-19 疫苗生产商，2024 年秋季的新疫苗应针对今年早些时候占主导地位的 JN.1 变种。美国食品和药物管理局的这一建议与欧洲和世界卫生组织的建议一致，在此之前，美国该机构的顾问们以压倒性多数支持以较老的 JN.1 株为目标，而不是现在占主导地位的 KP.2 株。另外，另一家疫苗生产商莫德纳   周五表示，它已向美国食品与药物管理局 提交了 针对JN.1菌株的 COVID-19疫苗申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTX","LU0456855351.SGD","BK4535","SGXZ57979304.SGD","BK4592","SG9999011175.SGD","SG9999001176.SGD","BK4585","SG9999013999.USD","BK4532","IE0002270589.USD","LU1023059063.AUD","BK4501","LU0058720904.USD","SG9999001176.USD","IE00BBT3K403.USD","BK4588","LU1057294990.SGD","BK4581","LU1066051498.USD","SG9999002224.SGD","PFE","BK4139","BK4548","LU0289739699.SGD","BK4568","BK4007","BK4533","IE00B19Z3B42.SGD","IE00B19Z3581.USD","SG9999003800.SGD","MRNA","IE00BLSP4452.SGD","LU0868494617.USD","BK4534","BK4551","LU0170899867.USD","BK4550","SG9999002232.USD","LU1066053197.SGD","IE00BLSP4239.USD","LU0234572021.USD","NVAX","LU0122379950.USD"],"gpt_icon":0},{"id":"2441706109","title":"诺瓦瓦克斯医药盘中异动 早盘快速下挫5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441706109","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441706109?lang=zh_cn&edition=full","pubTime":"2024-06-07 21:51","pubTimestamp":1717768314,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日21时51分，诺瓦瓦克斯医药股票出现异动，股价大幅下跌5.09%。诺瓦瓦克斯医药股票所在的生物技术行业中，整体跌幅为0.09%。消息层面，截至21时51分，《盘前涨约16% 诺瓦瓦克斯医药新冠疫苗上市申请获FDA审查》资讯为影响诺瓦瓦克斯医药的重要信息。此前，诺瓦瓦克斯医药周三表示，将于9月推出最新的新冠疫苗，但需获得美国监管机构的授权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607215155af8ca9b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607215155af8ca9b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVAX","BK4568","BK4585","BK4139","BK4547","BK4588"],"gpt_icon":0},{"id":"2441174337","title":"美股三大指数集体高开 蔚来绩后跌超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441174337","media":"腾讯自选股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441174337?lang=zh_cn&edition=full","pubTime":"2024-06-06 21:31","pubTimestamp":1717680690,"startTime":"0","endTime":"0","summary":"美股三大指数集体高开，道指涨0.05%，纳指涨0.08%。英伟达开盘涨超1%，公司将在明日收盘后进行拆股；蔚来跌超6%，公司第一季度营收低于预期。诺瓦瓦克斯医药涨逾13%，公司预计将在9月为针对JN.1变异株的新冠疫苗交付做好准备。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606211843aef3d0d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606211843aef3d0d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4555","EVS.SI","BK4585","BK4531","NIO.SI","BK4581","BK4526","BK4574","BK4504","BK4568","LU0320764599.SGD","BK4505","BK4532","BK4548","BK4139","BK4547","BK4588","BK4099","LU0052750758.USD","LU0708995583.HKD","NVDA","NIO","NVAX","09866","BK4509","BK4534"],"gpt_icon":0},{"id":"2441712514","title":"BUZZ--美国股票走势-罗宾hood、JM Smucker、Novavax","url":"https://stock-news.laohu8.com/highlight/detail?id=2441712514","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441712514?lang=zh_cn&edition=full","pubTime":"2024-06-06 21:18","pubTimestamp":1717679913,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      6月6日 - 标普500指数和道指期货周四在震荡交投中走低，此前失业救济金申请数据显示美国劳动力市场日益疲软，而纳斯达克指数期货表现出色，原因是人工智能热门股Nvidia的上涨提振了科技板块的乐观情绪。美东时间9:01，道指电子盘  下跌0.01%，报38881点。标普500指数小型股  上涨0.01%，报5366.5点；纳斯达克100指数小型股  上涨0.11%，报19095点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPC","LU0061475181.USD","PBF","LU0320765059.SGD","LU1861220207.SGD","LULU","LU1861217088.USD","LU0456854461.SGD","BK4588","BK4212","NVDA","GPCR","BK4144","DLTR","ACHR","BK4023","IE00BFSS7M15.SGD","VSTO","BK4200","LU0276348264.USD","VSCO","BK4587","BK4166","SJM","VNDA","BK4127","BUZZ","COF","HOOD","SMAR","BK4549","BK4155","FIVE","NVAX","IE0009356076.USD","LPG","BK4548","DINO","BK4543","BIG","DK","LU0266512127.USD","BK4220","ABM","ANNX","BK4547","IE00BMPRXR70.SGD","LU0348723411.USD","LU0823411888.USD","CXM"],"gpt_icon":0},{"id":"2441371958","title":"盘前涨约16% 诺瓦瓦克斯医药(NVAX.US)新冠疫苗上市申请获FDA审查","url":"https://stock-news.laohu8.com/highlight/detail?id=2441371958","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441371958?lang=zh_cn&edition=full","pubTime":"2024-06-06 20:30","pubTimestamp":1717677015,"startTime":"0","endTime":"0","summary":"周四美股盘前，诺瓦瓦克斯医药上涨约16%，此前该生物技术公司表示，美国食品药品监督管理局(FDA)已接受审查其新冠疫苗的上市申请。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20240606/20240606203044_72639.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240606/20240606203044_72639.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1132352.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4547","BK4139","BK4568","BK4588","NVAX","BK4585","159646"],"gpt_icon":0},{"id":"2441716915","title":"BUZZ-美国 FDA 顾问建议在 2024-25 年期间注射 COVID-19 疫苗后，Novavax 公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2441716915","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441716915?lang=zh_cn&edition=full","pubTime":"2024-06-06 20:23","pubTimestamp":1717676617,"startTime":"0","endTime":"0","summary":"    6月6日 - ** Novavax  股价盘前上涨16%至24.31美元 ** 周三晚些时候，美国卫生监管机构的顾问建议 ，2024-25年的COVID-19疫苗应针对今年占主导地位的JN.1变种。** NVAX 曾在 5 月份表示 ，只有 监管机构接受其 针对较早 JN.1 变异株的疫苗，它才能在今年秋季在美国提供 COVID-19 疫苗。** NVAX公司表示，预计该疫苗将于9月投入商业生产** 莫德纳   公司开发了基于mRNA的COVID-19疫苗，该公司股价盘前上涨2.4%，报158.5美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4568","BNTX","BK4501","BK4547","BK4548","BK4585","MRNA","NVAX","BK4139","BUZZ","BK4533","BK4535","BK4551","BK4588","BK4532"],"gpt_icon":0},{"id":"1102272319","title":"盘前 | 蔚来绩后大跌！诺瓦瓦克斯涨超23%；马斯克的星舰今晚将展开第四次试飞","url":"https://stock-news.laohu8.com/highlight/detail?id=1102272319","media":"老虎资讯综合","labels":["movement"],"top":-1,"share":"https://www.laohu8.com/m/news/1102272319?lang=zh_cn&edition=full","pubTime":"2024-06-06 20:00","pubTimestamp":1717675202,"startTime":"0","endTime":"0","summary":"美国监管盯上英伟达、微软、OpenAI三巨头据媒体报道，美国监管机构已经达成一项协议，将继续对微软、OpenAI和英伟达在人工智能行业的主导地位进行反垄断调查。具体而言，司法部将牵头调查英伟达作为全球最大芯片制造商是否违反了反垄断法，FTC将主导对OpenAI和微软的反垄断调查。有分析称，这是美国监管部门对AI反垄断调查升级的最有力信号。好消息接踵而至，$诺瓦瓦克斯医药$盘前涨超23%。","market":"us","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0170899867.USD","BK4592","NVAX","IE00BJJMRX11.SGD","LU0079474960.USD","NIO","IE00BLSP4239.USD","BK4528","MSFT","LU0234570918.USD","LU0238689110.USD","LU0417517546.SGD","IE00B3S45H60.SGD","NVDA","BK4516","NIO.SI","IE00BLSP4452.SGD","LU0072462426.USD","LU0109391861.USD","09866"],"gpt_icon":1},{"id":"2441715933","title":"诺瓦瓦克斯医药(NVAX)盘前升逾19% 公司预计准备于9月提供最新的JN.1新冠肺炎疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2441715933","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441715933?lang=zh_cn&edition=full","pubTime":"2024-06-06 19:53","pubTimestamp":1717674782,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺瓦瓦克斯医药(NVAX)盘前骤升，截止发稿，涨19.17%，报24.99美元。此前美FDA指出，一种名为KP.2的亚变种自4月底以来已成为美国的主要毒株。据该机构称，这种新毒株是一种Jn.1衍生的亚变种，包含两个新的额外突变。诺瓦瓦克斯表示，预计准备于9月提供最新的JN.1新冠肺炎疫苗，现正等待授权。诺瓦瓦克斯医药公司表示Jn.1疫苗在非临床模型中生成广泛的中和反应可针对Jn.1-谱系亚型变异株，此前公司表示Jn.1疫苗的首批货物计划于八月抵达美国仓库。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/MzE4MDg0MTAxNw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MzE4MDg0MTAxNw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"276539","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVAX","BK4585","BK4588","BK4547","BK4568","BK4139","159646"],"gpt_icon":0},{"id":"2441927313","title":"疫苗制造商称，针对 JN.1 变异株的 COVID 疫苗可中和较新的菌株","url":"https://stock-news.laohu8.com/highlight/detail?id=2441927313","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441927313?lang=zh_cn&edition=full","pubTime":"2024-06-05 20:47","pubTimestamp":1717591632,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透6月5日 - 生产COVID-19疫苗的公司说，动物实验数据显示，它们针对今年早些时候占主导地位的JN.1变种的2024-25针疫苗对KP.2等较新亚变种的中和效果比老疫苗好得多。辉瑞  及其合作伙伴BioNTech  将在获得批准后立即供应更新的疫苗，而莫德纳  和Novavax  则预计在8月份上市。 这是两家公司在周三美国食品和药物管理局顾问会议前的一份报告中透露的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4533","BK4551","BK4585","NVAX","BK4501","MRNA","BK4532","BK4548","BK4139","BK4588","PFE","BK4534"],"gpt_icon":0},{"id":"2440231899","title":"诺瓦瓦克斯医药盘中异动 早盘股价大跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440231899","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440231899?lang=zh_cn&edition=full","pubTime":"2024-06-04 22:30","pubTimestamp":1717511433,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日22时30分，诺瓦瓦克斯医药股票出现波动，股价急速下挫5.43%。截至发稿，该股报17.23美元/股，成交量445.429万股，换手率3.02%，振幅4.97%。诺瓦瓦克斯医药股票所在的生物技术行业中，整体涨幅为0.57%。诺瓦瓦克斯医药公司简介：诺瓦瓦克斯医药公司是一家开发疫苗的生物技术公司。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗，以应对已知和新出现的疾病威胁。该公司认为，其疫苗技术有可能广泛应用于各种人类传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604223033941ec47e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604223033941ec47e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","NVAX","BK4139","BK4585","BK4547","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.novavax.com","stockEarnings":[{"period":"1week","weight":-0.092},{"period":"1month","weight":-0.153},{"period":"3month","weight":1.8102},{"period":"6month","weight":1.6033},{"period":"1year","weight":0.7133},{"period":"ytd","weight":1.6521}],"compareEarnings":[{"period":"1week","weight":0.0048},{"period":"1month","weight":0.0341},{"period":"3month","weight":0.0511},{"period":"6month","weight":0.1633},{"period":"1year","weight":0.2302},{"period":"ytd","weight":0.1473}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novavax, Inc.是一家新型临床阶段生物制药公司，致力于发现、开发和商业化纳米颗粒重组疫苗和佐剂。公司的疫苗技术平台是根据专有纳米疫苗重组技术开发的，包括病毒样颗粒和蛋白质纳米颗粒候选疫苗。公司的候选疫苗是转基因的三维纳米结构，结合了免疫重要蛋白。公司的疫苗产品针对各种传染病，还有目前在临床开发的针对呼吸道合胞体病毒(RSV)、季节性流感和大流行性流感的产品。此外，CPL生物制剂私人有限公司(CPLB)，其合资公司在印度，正积极开发一系列疫苗候选产品，是由诺瓦瓦克斯公司转基因完成的。1987年，诺瓦瓦克斯公司在特拉华州的法律下成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.655172,"avgChangeRate":0.101878},{"month":2,"riseRate":0.586207,"avgChangeRate":0.042134},{"month":3,"riseRate":0.275862,"avgChangeRate":-0.034367},{"month":4,"riseRate":0.448276,"avgChangeRate":0.007943},{"month":5,"riseRate":0.517241,"avgChangeRate":0.126888},{"month":6,"riseRate":0.517241,"avgChangeRate":0.09837},{"month":7,"riseRate":0.551724,"avgChangeRate":0.017958},{"month":8,"riseRate":0.535714,"avgChangeRate":0.039529},{"month":9,"riseRate":0.464286,"avgChangeRate":-0.045486},{"month":10,"riseRate":0.321429,"avgChangeRate":0.038967},{"month":11,"riseRate":0.357143,"avgChangeRate":0.005457},{"month":12,"riseRate":0.392857,"avgChangeRate":-0.03691}],"exchange":"NASDAQ","name":"诺瓦瓦克斯医药","nameEN":"Novavax"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺瓦瓦克斯医药(NVAX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺瓦瓦克斯医药(NVAX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺瓦瓦克斯医药,NVAX,诺瓦瓦克斯医药股票,诺瓦瓦克斯医药股票老虎,诺瓦瓦克斯医药股票老虎国际,诺瓦瓦克斯医药行情,诺瓦瓦克斯医药股票行情,诺瓦瓦克斯医药股价,诺瓦瓦克斯医药股市,诺瓦瓦克斯医药股票价格,诺瓦瓦克斯医药股票交易,诺瓦瓦克斯医药股票购买,诺瓦瓦克斯医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺瓦瓦克斯医药(NVAX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺瓦瓦克斯医药(NVAX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}